This page is updated frequently with new Peritoneal-related patent applications.
|Neo-islets comprising stem and islet cells and treatment of diabetes mellitus therewith|
Described are neo-islets comprising: a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells where the cells have been treated so as to facilitate redifferentiation. Further described herein are methods of generating neo-islets, the methods comprising: culturing a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells; on a surface that promotes the formation of cell clusters.
|Method and performing peritoneal ultrafiltration|
Method and apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a cassette having four inlets/outlets. A patient tube is connected to a patient connector, intended to be connected to a patient line for access to a peritoneal cavity of the patient.
|Detecting a heater bag|
In one aspect, a peritoneal dialysis (pd) machine can be used to detect a heater bag filled with dialysate. The pd machine has a heater tray that includes a temperature sensor and also has a processor that determines a status of the heater bag based on data received from the temperature sensor.
Fresenius Medical Care Holdings, Inc.
|Mesothelin vaccines and model systems|
Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic t cell response.
The Johns Hopkins University
|Systems for utilizing the water content in fluid from a renal replacement therapy process|
The present invention relates to systems, methods and uses for recycling at least a part of water lost during various renal replacement therapy processes, e.g. In the preparation of a fresh dialysate solution or fresh reconstitution fluid for kidney disease dialysis and hemofiltration by utilizing water from the spent fluids.
Aquapoten Company Limited
|Hybrid blood and peritoneal dialysis treatment systems and methods|
A dialysis system includes a fluid line fluidly communicating with a fluid source, a peritoneal dialysis unit configured to be placed in fluid communication with the fluid line, the peritoneal dialysis unit including a first user interface and a first control unit, the first user interface configured to receive first user inputs related to a peritoneal dialysis treatment, the first control unit configured to operate the peritoneal dialysis unit in accordance with the first user inputs to perform the peritoneal dialysis treatment, and a blood treatment unit configured to be placed in fluid communication with the fluid line, the blood treatment unit including a second user interface and a second control unit, the second user interface configured to receive second user inputs related to a blood treatment, the second control unit configured to operate the blood treatment unit in accordance with the second user inputs to perform the blood treatment.. .
Baxter Healthcare Sa
|Voice interface for a dialysis machine|
A dialysis machine (e.g., a peritoneal dialysis (pd) machine) can include a microphone and a component that provide voice recognition capabilities to the machine. For example, in some implementations, the component is configured to identify and/or authenticate voice commands that are issued by a user.
Fresenius Medical Care Holdings, Inc.
|Dialysis catheter and methods of use thereof|
The present invention relates generally to medical devices for use in peritoneal dialysis and to methods of using such devices. One aspect of the invention provides a device including an elongated tubular member having a lumen extending from a proximal end to a distal end and a first expandable member positioned around the elongated tubular member at a first position.
Cook Medical Technologies Llc
|System and monitoring the health of dialysis patients|
A system and method for monitoring the health of dialysis patients with raman spectroscopy measurements of one or more target analytes is described. The methods include irradiating one or more fluids of interest with light to produce one or more spectrum and detecting the spectrum with a detector.
Virginia Tech Intellectual Properties, Inc.
|Systems and methods for delivery of peritoneal dialysis (pd) solutions with integrated inter-chamber diffuser|
The invention provides, in some aspects, a container system for medical solutions such as peritoneal dialysis (pd) solutions. The invention particularly features a system which includes a first compartment that contains a first medical solution, e.g., a pd osmotic agent, and a second compartment that contains a second medical solution, e.g., a pd buffer agent.
Fresenius Medical Care Holdings, Inc.
Visually assisted entry of a veress needle with a tapered videoscope for microlaparoscopy
A veress needle is modified to receive a forward-looking miniature videoscope through the cannula of an insufflation tube of the veress needle. The modified instrument enables direct viewing of progress of the instrument through tissue to the peritoneal cavity of a patient, for proper location of the needle and insufflation of the cavity via the needle.
Image analysis assessment of peritoneal dialysis complication in peritoneal dialysis
An image analysis method and an apparatus thereof for assessment of pd (peritoneal dialysis) complications in peritoneal dialysis are provided. An analysis procedure is executed on an image under test of a dialysis bag, so as to obtain a color location in a color space corresponding to the image under test.
National Taiwan University
Tissue repair implant
Described herein are tissue repair implants comprising at least a first layer of peritoneal membrane. The first layer of peritoneal membrane can be located adjacent to a second layer of peritoneal membrane and can be in direct contact with the second layer of peritoneal membrane.
Proxy Biomedical Limited
Method of retroperitoneal lateral insertion of spinal implants
A method is disclosed for introducing a spinal disc implant into an intervertebral space of a subject. The subject is placed in a lateral position, and the anterior face of the spinal disc intervertebral space is accessed, between the l5 and s1 vertebrae, from an anterior and lateral retroperitoneal approach.
Pantheon Spinal Llc
Substituted aromatic sulfur compounds and methods of their use
Wherein d, n, ra, rb, and rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula ii for treating or reducing the risk of peritoneal carcinomatosis in a patient.. .
A process for the estimation of treatment duration of peritoneal dialysis treatment
The present invention relates to a process for the estimation of treatment duration of peritoneal dialysis treatment: wherein the estimation of treatment duration is performed based on an ideal treatment duration, wherein the ideal treatment duration is increased by one or more delay values, wherein the delay values depend on one or more apparatus-specific and/or patient-specific and/or process-specific parameters.. .
Fresenius Medical Care Deutschland Gmbh
Apparatus and methods for facilitating treatment of tissue via improved delivery of energy based and non-energy based modalities
Methods and apparatus for accessing and treating regions of the body are disclosed herein. Using an endoscopic device having an automatically controllable proximal portion and a selectively steerable distal portion, the device generally may be advanced into the body through an opening.
Intuitive Surgical Operations, Inc.
Device for vascular and peritoneal access and a device for hemodialysis
An implantable device for venous or peritoneal access including a housing including a void having distal a proximal openings; an insert for insertion through the proximal opening comprising a venous or peritoneal catheter; a valve element mounted in a cylindrical recess of the insert; an extracorporeal coupling member of which a terminal portion can be inserted into a proximal recess of the valve element; one or two conduits extending from the catheter to the proximal end of the coupling member via the valve element and the insert for providing fluid communication, which can be interrupted by rotating the coupling member. The coupling member can be extracted from the recess only in a state of interrupted communication..
Apparatus and method and for monitoring and controlling a peritoneal dialysis therapy
An apparatus for performing peritoneal dialysis includes a housing; a peritoneal dialysis supply bag supported by and/or located above the housing; a first valve for controlling gravity flow of fresh peritoneal dialysis fluid from the supply bag to a patient; a second valve for controlling gravity flow of used peritoneal dialysis fluid from the patient to a drain; and a pressure sensor positioned and arranged with respect to the gravity flow of fresh peritoneal dialysis fluid or the gravity flow of used peritoneal dialysis fluid to provide a reading used to evaluate a head height pressure.. .
Baxter International Inc.
Compositions and methods for treating peritoneal cancers
The present disclosure provides compositions and methods for treating a peritoneal cancer in a subject. The methods include administering a t cell which is genetically modified to express a chimeric t cell receptor protein.
Prospect Chartercare Rwmc, Llc D/b/a Roger Williams Medical Center
Surgical drape for use in cesarean sections
A surgical drape allows access to a vaginal area during cesarean sections without breaking a sterile field. The drape comprises a base sheet defined by an incision panel that overlays a peritoneal region, where the cesarean section primarily occurs; and a vagina panel that overlays a vaginal area.
Peritoneal cavity simulator
Provided is a peritoneal cavity simulator that can simplify the execution of alignment during the replacement of living-body-feeling model organs for repeated trainings on a simulator. This peritoneal cavity simulator comprises: a casing that has a pelvis part, a back part, and an abdomen part; living-body-feeling model organs; and model holding parts.
Fasotec Co., Ltd.
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
The present invention provides methods for treatment or prophylaxis of viruses, particularly influenza virus, by administration of agents, particularly neutralizing antibodies or active fragments thereof, directly to the respiratory tract, including by intranasal or inhalation administration. The invention provides compositions suitable for intranasal or inhalation treatment and administration.
Gas recirculation system and method
Gas recirculation systems for use in endoscopic surgical procedures including a gas recirculation pump are disclosed. The gas recirculation pump may work in conjunction with an insufflator used to inflate a patient's peritoneal cavity during surgery.
Northgate Technologies Inc.
Peritoneal dialysis systems and methods
Described are peritoneal dialysis systems and methods that involve the use of first and second stage filtration of a used dialysate withdrawn from the peritoneal space of a patient. The first filtration stage forms a first retentate containing an osmotic agent and a first permeate containing water and nitrogen-containing waste products of the patient.
Cook Medical Technologies Llc
System and performing alternative and sequential blood and peritoneal dialysis modalities
A dialysis system includes at least one source of fluid for dialysis, a fluid line in fluid communication with the at least one source of fluid, at least one pump positioned and arranged to pump fluid from the at least one source of fluid through the fluid line, a first patient connector configured to be removably placed in fluid communication with the fluid line to allow a blood treatment to be performed using the at least one source of fluid, and a second patient connector configured to be removably placed in fluid communication with the fluid line to allow a peritoneal dialysis treatment to be performed using the at least one source of fluid.. .
Baxter Healthcare S.a.
Methods for producing high concentration lyophilized pharmaceutical formulations
The present invention relates to methods of producing lyophilized pharmaceutical compositions comprising a high concentration of therapeutic protein or antibody prior to lyophilization, wherein the lyophilized formulation can be reconstituted with a diluent in about 15 minutes or less. The invention also relates to the high concentration lyophilized formulations produced by the methods described herein.
Merck Sharp & Dohme Corp.
Transcutaneous measurement of hemoglobin changes to calculate estimated blood volume change during peritoneal dialysis
An embodiment of the disclosure provides a method for measuring change in blood volume using a transcutaneous measurement system applied to a patient's skin. The method involves placing a sensor in contact with the skin of a patient, where the sensor includes a light emitter and a photodetector.
Fresenius Medical Care Holdings, Inc.
Nitrogenous heterocyclic derivatives and their application in drugs
The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, ipf, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis..
Sunshine Lake Pharma Co., Ltd.